US-Keytruda®

DRUG2 trials

Sponsors

Bio-Thera Solutions

Conditions

Carcinoma, Non-Small-Cell Lung

Phase 1

A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants

Active, not recruitingNCT07180862

Bio-Thera SolutionsCarcinoma, Non-Small-Cell Lung

Start: 2025-10-14End: 2027-11-30Target: 160Updated: 2026-09-02

Phase 3

A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC

TerminatedNCT06280196

Bio-Thera SolutionsCarcinoma, Non-Small-Cell Lung

Start: 2024-07-19End: 2025-07-30Updated: 2025-12-02